Biochemical Engineering
Pharmaron acquires UK biomanufacturing site from AbbVie
28th February 2021
Pharmaron Beijing Co., Limited announced today that it has entered into a definitive agreement to acquire Allergan Biologics Limited (“The ABL site”) in Liverpool, UK, for US$118.7 million in cash from AbbVie. The transaction is expected to close in the second quarter of 2021, subject to the satisfaction of customary closing conditions. Source: BusinessWire 28/2/2021
Back to group news